Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Rockwell Medical (NASDAQ:RMTI) reported its Q3 earnings results on Tuesday, November 14, 2023 at 06:00 AM.
Here's what investors need to know about the announcement.
Rockwell Medical beat estimated earnings by 30.0%, reporting an EPS of $-0.07 versus an estimate of $-0.1.
Revenue was up $5.08 million from the same period last year.
Last quarter the company missed on EPS by $0.06 which was followed by a 3.16% drop in the share price the next day.
Here's a look at Rockwell Medical's past performance:
Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
---|---|---|---|---|
EPS Estimate | -0.12 | -0.16 | -0.39 | -0.48 |
EPS Actual | -0.18 | -0.10 | -0.20 | -0.40 |
Revenue Estimate | 18.08M | 19.12M | 16.31M | 19.37M |
Revenue Actual | 18.08M | 19.67M | 19.31M | 18.69M |
To track all earnings releases for Rockwell Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: RMTI